J
János Gyenis
Researcher at University of Pannonia
Publications - 38
Citations - 1036
János Gyenis is an academic researcher from University of Pannonia. The author has contributed to research in topics: PLGA & Particle size. The author has an hindex of 16, co-authored 36 publications receiving 896 citations. Previous affiliations of János Gyenis include Hungarian Academy of Sciences & Information Technology University.
Papers
More filters
Journal ArticleDOI
Preparation of chitosan particles suitable for enzyme immobilization.
TL;DR: Activity of beta-galactosidase covalently attached to differently sized particles have been evaluated and compared and the highest activity was shown by the biocatalyst immobilized on nanoparticles obtained by means of the ionotropic gelation method with sodium sulphate as gelation agent.
Journal ArticleDOI
Photocatalytic decomposition of NO by TiO2 particles
TL;DR: In this article, the effects of initial NO concentration, gas-residence time, reaction temperature and ultraviolet (UV) light intensity on the photocatalytic decomposition of NO have been determined in an annular flow-type and a modified two-dimensional fluidized-bed photoreactors.
Journal ArticleDOI
Optimization of protein encapsulation in PLGA nanoparticles
TL;DR: In this article, the authors investigated the efficiency of encapsulation of bovine serum albumin (BSA) in poly( dl -lactic-co-glycolic acid) (PLGA) nanoparticles produced by w1/o/w2 (water-in-oil-inwater) double emulsion-solvent evaporation method.
Journal ArticleDOI
Comparison of the preparation of PLGA–BSA nano- and microparticles by PVA, poloxamer and PVP
TL;DR: In this paper, Bovine serum albumin (BSA) model protein was encapsulated by poly( d, l -lactide- co -glycolide) (PLGA) using a multiple water-in-oil-inwater emulsion-solvent evaporation technique.
Journal ArticleDOI
Influence of process conditions on the mean size of PLGA nanoparticles
TL;DR: In this article, the influence of process conditions on the volume mean size of PLGA nanoparticles intended as drug delivery vehicle for an injection formula of protein type therapeutic agent was investigated.